HMGB1 and Mental deterioration: Inhibition of microglial activation or blockade of high-mobility group box 1 (HMGB1) release can prevent chronic pain–induced cognitive decline (Hisaoka-Nakashima et al., 2022b; Hisaoka-Nakashima et al., 2022a).